Formation Bio

Formation Bio is a tech-driven pharmaceutical company based in New York City, founded in 2014. The company focuses on improving the efficiency of drug development to bring new treatments to patients more quickly. It operates as a fully integrated pharma company, acquiring clinical-stage drug candidates from pharmaceutical companies, biotechnology firms, and academic institutions, particularly those at the pre-Phase 2 stage. The company utilizes a proprietary technology platform that enhances patient recruitment, site management, study monitoring, and real-time data analysis. This approach allows Formation Bio to conduct clinical trials more rapidly and cost-effectively than traditional methods. It typically advances drug candidates through clinical development over two to three years before monetizing them by licensing or selling to larger pharmaceutical companies. Formation Bio's innovative model also supports smaller biotech firms by providing access to capital and development capabilities without the need for extensive internal resources. Its focus areas include rheumatology, dermatology, central nervous system disorders, and cardiometabolic diseases.